Determination of hepatic galactose elimination capacity using 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT: reproducibility of the method and metabolic heterogeneity in a normal pig liver model
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
A PET method is developed for non-invasive measurement of regional metabolic liver function using the galactose analog 2-[¹⁸F]fluoro-2-deoxy-D-galactose, FDGal. The aim of the present study was to determine the reproducibility of the method in pigs before translating it to human studies.